Abstract
A series of novel 1,2,3-triazole and isoxazole-linked pyrazole derivatives have been synthesized from pyrazole and triazole/isoxazole scaffolds. The synthesized congeners were evaluated for their anti-proliferative efficacy in four cancer cell lines (MCF7, HEPG2, IMR32, and HELA). Majority of the compounds demonstrated potent cytotoxic activities, among them 4k and 4l showed significant cytotoxicity in all the tested cell lines.
Graphical Abstract
Similar content being viewed by others
References
Al-Saadi MS, Rostom SAF, Faid Allah HM (2005) In vitro antitumor screening of some polysubstituted pyrazole analogs. Saudi Pharm J 13:89–96
Buckle DR, CJM Rockell, Smith H, Spicer BA (1986) (Piperazinylalkoxy)[l]benzopyrano[2,3-d]-1,2,3-triazol-9(1H)-ones with combined H,-antihistamine and mast cell stabilizing properties. J Med Chem 29:2262
Duncan WJ, Maria YV, Michael C, Rong LL, Wang J (2011) Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry. J Med Chem 54:765
El-Deeb IM, Lee SH (2010) Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity. Bioorg Med Chem 18:3961–3973
Farag AM, Mayhoub AS, Barakat SE, Bayomi AH (2008) Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives. Bioorg Med Chem 16:881–889
Ferreira SB, Sodero ACR, Cardoso MFC, Lima ES, Kaiser CR, Silva FP, Ferreira VF (2010) Synthesis, biological activity, and molecular modeling studies of 1h-1,2,3-triazole derivatives of carbohydrates as α-glucosidases inhibitors. J Med Chem 53:2364
Finar IL and Godfrey KE (1954) The preparation and properties of some derivatives of 1 –Phenylpyrazole. J Chem Soc 2293
Gaede BJ, Mcdermott LL (1993) Novel perfluoroalkylsubstituted pyrazoles. 1. hydroxypyrazoles. J Heterocycl Chem 30:49–54
Genin MJ, Biles C, Keiser BJ, Poppe SM, Swaney SM, Tarpley WG, Yagi Y, Romero DL (2000) Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives. J Med Chem 43:1034–1040
Hansen TV, Wu P, Fokin VV (2005) One-pot copper(I)-catalyzed synthesis of 3,5-disubstituted isoxazoles. J Org Chem 70:7761
Insuasty B, Tigreros A, Orozco F, Quiroga J, Abonia R, Nogueras M, Sanchez A, Cobo J (2010) Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1Hpyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. Bioorg Med Chem 18:4965–4974
Lawrence SL, Roth V, Slinger R, Toye B, Gaboury I, Lemyre B (2005) Cloxacillin versus vancomycin for presumed late-onset sepsis in the neonatal intensive care unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. BMC Pediatr 5:49
Liu JJ, Zhao MY, Zhang X, Zhao X, Zhu HL (2013) Pyrazole derivatives as antitumor, anti inflammatory and antibacterial agents. Med Chem 13(13):1957–66
Madsen U, Slok FA, Stensbol TB, Brauner-Osborn H, Lutzhoft HCH, Poulsen MV, Eriksen L, Krogsgaard LP (2000) Ionotropic excitatory amino acid receptor ligands. Synthesis and pharmacology of a new amino acid AMPA antagonist. Eur J Med Chem 35:69–76
Maria AF, Vera D, Freitas ACC, Castro HC, Albuquerque SD, Cabral LM, Rodrigues CR, Albuquerque MG, Martins RCA, Henriques MGMO, Dias LRS (2009) Synthesis, antichagasic in vitro evaluation, cytotoxicity assays, molecular modeling and SAR/QSAR studies of a 2-phenyl-3-(1-phenyl-1H-pyrazol-4-yl)- acrylic acid benzylidene-carbohydrazide series. Bioorg Med Chem 17:295–302
Miller PC, Molyneaux JM (1999) One-pot synthesis of dimethyl [1-substituted-5-hydroxy-1H-pyrazol-4-yl]phosphonates. Org Prep Proced Int 31:295–304
Prakash O, Pannu K, Kumar A (2006) Synthesis of some new 2-(3-Aryl-1-phenyl-4-pyrazolyl)-benzoxazoles using hypervalent iodine mediated oxidative cyclization of Schiff’s Bases. Molecules 11:43–48
Raffa D, Daidone G, Maggio B, Cascioferro S, Plescia F, Schillaci D (2004) Synthesis and antileukemic activity of new 3-(1-phenyl-3-methylpyrazol-5-yl)-2-styrylquinazolin-4(3H)-ones. Farmaco 59:215–221
Ragavan RV, Vijayakumar V, Kumari NS (2010) Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles. Eur J Med Chem 45:1173–1180
Rashad AE, Hegab MI, Abdel-Megeid RE, Micky JA, Abdel-Megeid FME (2008) Synthesis and antiviral evaluation of some of new pyrazole and fused pyrazolopyrimidine derivatives. Bioorg Med Chem 16:7102–7106
Rostom SA (2010) Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents. Bioorg Med Chem 18:2767–2776
Rostom SAF, Shalaby MA, El-Demellawy MA (2003) Polysubstituted pyrazoles, part 5. Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HCV agents. Eur J Med Chem 38:959–974
Rozman B, Praprotnik S, Logar D, Tomsic M, Hijnik M, Golja KM, Dolenc P (2002) Leflunomide and hypertension. Ann Rheum Dis 61:567
Selwood DL, Brummell DG, Glen RC, Goggin MC, Reynolds K, Tatlock MA, Wishart G (2001) Solution-phase parallel synthesis of 5-carboxamido 1-benzyl-3-(3-dimethylaminopropyloxy)-1H-pyrazoles as activators of soluble guanylate cyclase with improved oral bioavailability. Bioorg Med Chem Lett 11:1089–1092
Shin KD, Lee MY, Shin DS, Lee S, Son HK, Sukhoon K, Young KP, Kwon BM, Han DC (2005) Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation. J Biol Chem 50:41439
Sperry JB, Wright Dl (2005) Furans, thiophenes and related heterocycles in drug discovery. Curr Opin Drug Discovery Dev 8:723
Wan Q, Chen J, Chen G, Danishefsky SJ (2006) A potentially valuable advance in the synthesis of carbohydrate-based anticancer vaccines through extended cycloaddition chemistry. J Org Chem 71:8244
Whiting M, Tripp JC, Lin YC, Lindstrom W, Olson AJ, Elder JH, Sharpless KB, Fokin VV (2006) Rapid discovery and structure−activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization. J Med Chem 49:7697
Zhang J, Didierlaurent S, Fortin M, Lefrancois D, Uridat E, Vevert JP (2000) Nonpeptide endothelin antagonists: from lower afinity pyrazol-5-ols to higher anity pyrazole-5-carboxylic acids. Bioorg Med Chem Lett 10:1351–1355
Acknowledgements
N.F. thanks DST (SR/WOS-A/CS-124/2012), India for the award of fellowship. G.S. and B.V.S.R thank CSIR, India for financial support as part of XII Five Year plan programmed under title ORIGIN (CSC-0108).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Madhavilatha, B., Fatima, N., Sabitha, G. et al. Synthesis of 1,2,3-triazole and isoxazole-linked pyrazole hybrids and their cytotoxic activity. Med Chem Res 26, 1753–1763 (2017). https://doi.org/10.1007/s00044-017-1884-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-017-1884-z